MetLife Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
124,277
+2,359
| +2% | +$21.1K | 0.01% | 1248 |
|
|
2025
Q1 | $914K | Sell |
121,918
-5,031
| -4% | -$37.7K | ﹤0.01% | 1418 |
|
|
2024
Q4 | $955K | Buy |
126,949
+7,199
| +6% | +$54.1K | 0.01% | 1444 |
|
|
2024
Q3 | $910K | Hold |
119,750
| – | – | 0.01% | 1444 |
|
|
2024
Q2 | $740K | Buy |
119,750
+30,780
| +35% | +$190K | ﹤0.01% | 1510 |
|
|
2024
Q1 | $452K | Sell |
88,970
-8,391
| -9% | -$42.6K | ﹤0.01% | 1734 |
|
|
2023
Q4 | $583K | Hold |
97,361
| – | – | ﹤0.01% | 1598 |
|
|
2023
Q3 | $689K | Hold |
97,361
| – | – | 0.01% | 1440 |
|
|
2023
Q2 | $685K | Hold |
97,361
| – | – | 0.01% | 1489 |
|
|
2023
Q1 | $812K | Hold |
97,361
| – | – | 0.01% | 1341 |
|
|
2022
Q4 | $1.12M | Hold |
97,361
| – | – | 0.01% | 1169 |
|
|
2022
Q3 | $1.23M | Hold |
97,361
| – | – | 0.01% | 1089 |
|
|
2022
Q2 | $1.03M | Hold |
97,361
| – | – | 0.01% | 1193 |
|
|
2022
Q1 | $1.58M | Buy |
97,361
+35,347
| +57% | +$575K | 0.01% | 1087 |
|
|
2021
Q4 | $859K | Hold |
62,014
| – | – | 0.01% | 1194 |
|
|
2021
Q3 | $891K | Sell |
62,014
-6,166
| -9% | -$88.6K | 0.01% | 1179 |
|
|
2021
Q2 | $1.08M | Hold |
68,180
| – | – | 0.01% | 1123 |
|
|
2021
Q1 | $693K | Sell |
68,180
-4,670
| -6% | -$47.5K | 0.01% | 1336 |
|
|
2020
Q4 | $543K | Buy |
72,850
+2,769
| +4% | +$20.6K | 0.01% | 1452 |
|
|
2020
Q3 | $241K | Hold |
70,081
| – | – | ﹤0.01% | 1753 |
|
|
2020
Q2 | $334K | Buy |
70,081
+30,992
| +79% | +$148K | ﹤0.01% | 1602 |
|
|
2020
Q1 | $78.2K | Sell |
39,089
-31,360
| -45% | -$62.7K | ﹤0.01% | 2186 |
|
|
2019
Q4 | $243K | Buy |
70,449
+19,861
| +39% | +$68.5K | ﹤0.01% | 1879 |
|
|
2019
Q3 | $145K | Hold |
50,588
| – | – | ﹤0.01% | 2124 |
|
|
2019
Q2 | $192K | Hold |
50,588
| – | – | ﹤0.01% | 2050 |
|
|
2019
Q1 | $412K | Hold |
50,588
| – | – | ﹤0.01% | 1577 |
|
|
2018
Q4 | $408K | Hold |
50,588
| – | – | 0.01% | 1493 |
|
|
2018
Q3 | $386K | Buy |
50,588
+7,707
| +18% | +$58.8K | ﹤0.01% | 1698 |
|
|
2018
Q2 | $246K | Hold |
42,881
| – | – | ﹤0.01% | 1822 |
|
|
2018
Q1 | $205K | Hold |
42,881
| – | – | ﹤0.01% | 1875 |
|
|
2017
Q4 | $211K | Buy |
+42,881
| New | +$211K | ﹤0.01% | 1904 |
|